Picopil is a new medcinal product in the expanding portfolio of Bestamed
BestaMed has officially marketed the Picopil medicinal product on March 10, 2019.
Picopil is another proof of the implementation of BestaMed’s long-term development strategy for dynamically increasing the portfolio of proprietary effective dosage forms that are successfully communicated through their own team of medical and commercial representatives and complete 360 ° marketing and commercial support for their own brands.